Impact of cancer cachexia on respiratory muscle function and the therapeutic potential of exercise

Ben T. Murphy,John J. Mackrill,Ken D. O'Halloran
DOI: https://doi.org/10.1113/JP283569
2022-10-19
Journal of Physiology
Abstract:Cancer cachexia is defined as a multi‐factorial syndrome characterised by an ongoing loss of skeletal muscle mass and progressive functional impairment, estimated to affect 50–80% of patients and responsible for 20% of cancer deaths. Elevations in the morbidity and mortality rates of cachectic cancer patients has been linked to respiratory failure due to atrophy and dysfunction of the ventilatory muscles. Despite this, there is a distinct scarcity of research investigating the structural and functional condition of the respiratory musculature in cancer, with the majority of studies exclusively focussing on limb muscle. Treatment strategies are largely ineffective in mitigating the cachectic state. It is now widely accepted that an efficacious intervention will likely combine elements of pharmacology, nutrition, and exercise. However, of these approaches, exercise has received comparatively little attention. Therefore, it is unlikely to be implemented optimally, whether in isolation or combination. In consideration of these limitations, the current review describes the mechanistic basis of cancer cachexia, and subsequently explores the available respiratory‐ and exercise‐focussed literature within this context. The molecular basis of cachexia is thoroughly reviewed. The pivotal role of inflammatory mediators is described. Unravelling the mechanisms of exercise‐induced support of muscle via antioxidant and anti‐inflammatory effects in addition to promoting efficient energy metabolism via increased mitochondrial biogenesis, mitochondrial function, and muscle glucose uptake provide avenues for interventional studies. Currently available pre‐clinical mouse models including novel transgenic animals provide a platform for the development of multi‐modal therapeutic strategies to protect respiratory muscles in people with cancer. figure legend Cancer cachexia is characterised by profound loss of skeletal muscle mass. Exercise has the potential to counteract several factors that contribute to muscle wasting. Atrophy and dysfunction of the ventilatory muscles can result in respiratory compromise and ultimately failure. There is a scarcity of research investigating structure and function of the respiratory musculature in cancer. Pre‐clinical and clinical studies focussed on mechanisms of exercise‐induced support of muscle are required to drive the development of multi‐modal therapeutic strategies to protect respiratory muscles in people with cancer. This article is protected by copyright. All rights reserved
What problem does this paper attempt to address?